Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the ...

Abstract: Increasing computation demand of machine learning (ML) applications (recommender system, image classification, speech recognition, and so on) calls for the development of specialized ...

Replicating the brain's capabilities, an impossible task, may theoretically require thousands of H100, one of NVIDIA's most ...

May 2026 - Latest assays from Touro prospect show strong copper equivalent grades and high precious metal values, with new ...

A research team led by Prof. Hao Ning of the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, in ...

CFTR modulators, especially triple therapy, significantly improve sinonasal inflammation and nasal polyp size in patients with cystic fibrosis.

The human body responds to music with the same reward system as more tangible pleasures associated with food, drugs and sex.

Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF), today announced the ...

Molecular genomics technology provider Agena Bioscience has launched the CFTR 100+ panel, a multiplex genotyping solution ...

Some were allowed their phone nearby but given firm instructions not to use it (the resistor group). And a final group was left to manage sans smartphone for the full six minutes (the control group).

The study highlights early microvascular impairment in adolescents with type 1 diabetes, emphasizing the importance of monitoring vascular health in this group.